Erythrocyte Marker Antibody / Erythrocyte Marker Antibodies

Erythrocyte Marker Antibody Overview

Erythrocyte Marker Antibody reagents target proteins specific to erythrocytes, or red blood cells (RBCs), the most abundant circulating cells in the human body. Erythrocytes are responsible for transporting oxygen from the lungs to tissues and removing carbon dioxide as waste. Their unique biconcave shape, flexibility, and hemoglobin content allow them to sustain life by delivering oxygen efficiently.

Key erythrocyte markers include glycophorin A (GYPA), band 3 protein (SLC4A1), hemoglobin subunits, and CD235a. These proteins are central to erythrocyte structure, stability, and oxygen transport. Because erythrocyte disorders such as anemia, thalassemia, and sickle cell disease affect millions globally, the Erythrocyte Marker Antibody provides critical tools for studying red cell biology and pathology. Meanwhile, Erythrocyte Marker Antibodies more broadly support diagnostics, transfusion medicine, and translational hematology.

Why Choose Erythrocyte Marker Antibodies from NSJ Bioreagents?

NSJ Bioreagents offers Erythrocyte Marker Antibodies validated for immunohistochemistry, western blotting, immunofluorescence, ELISA, and flow cytometry. Each Erythrocyte Marker Antibody undergoes rigorous validation to ensure strong specificity and minimal cross-reactivity.

By selecting Erythrocyte Marker Antibodies from NSJ Bioreagents, researchers gain access to reagents optimized for reproducibility. Our antibodies provide strong staining in blood smears and bone marrow sections, reliable detection in lysates, and consistent results across different assays. Detailed datasheets, positive controls, and validated protocols further ensure accuracy in hematology and pathology studies.

Applications of Erythrocyte Marker Antibodies

The Erythrocyte Marker Antibody supports diverse applications in hematology, pathology, and translational medicine.

1) Red Blood Cell Biology

• Erythrocyte Marker Antibodies detect proteins central to oxygen transport such as hemoglobin and band 3.

• The Erythrocyte Marker Antibody clarifies erythrocyte development from progenitors.

• Erythrocyte Marker Antibodies support research into membrane stability and red cell deformability.

2) Anemia and Hemoglobinopathies

• Erythrocyte Marker Antibodies identify molecular defects in sickle cell disease and thalassemias.

• The Erythrocyte Marker Antibody helps monitor abnormal hemoglobin variants.

• Erythrocyte Marker Antibodies are applied in translational research on gene and drug therapies.

3) Diagnostics and Clinical Pathology

• Erythrocyte Marker Antibodies are used in immunophenotyping to confirm red blood cell lineage.

• The Erythrocyte Marker Antibody provides clarity in bone marrow biopsies.

• Erythrocyte Marker Antibodies support laboratory diagnostics in anemia and hemolytic disorders.

4) Oncology and Hematology

• Erythrocyte Marker Antibodies distinguish erythroid lineage from other hematopoietic cells.

• The Erythrocyte Marker Antibody helps in classification of erythroid leukemias.

5) Transfusion Medicine

• Erythrocyte Marker Antibodies detect blood group antigens such as glycophorin A.

• The Erythrocyte Marker Antibody supports compatibility testing and transfusion safety.

• Erythrocyte Marker Antibodies are applied in research to reduce alloimmunization.

6) Infectious Disease

• Erythrocyte Marker Antibodies support malaria research by highlighting parasite–RBC interactions.

• The Erythrocyte Marker Antibody clarifies invasion pathways of Plasmodium species.

7) Translational Medicine and Regenerative Research

• Erythrocyte Marker Antibodies validate differentiation of stem cells into erythroid cells.

• The Erythrocyte Marker Antibody ensures lineage specification in tissue engineering.

• Erythrocyte Marker Antibodies are applied in clinical trials of red cell replacement therapies.

Why Are Erythrocyte Marker Antibodies Important?

Erythrocytes are fundamental to oxygen delivery and systemic health, and the Erythrocyte Marker Antibody provides an essential tool for studying them. The Erythrocyte Marker Antibodies portfolio more broadly supports hematology, pathology, and translational science.

In basic research, these antibodies clarify erythrocyte structure and development. In clinical research, the Erythrocyte Marker Antibody identifies abnormalities underlying anemia, hemoglobinopathies, and blood group disorders. In transfusion medicine, Erythrocyte Marker Antibodies ensure patient safety through compatibility testing.

Clinically, erythrocyte markers are vital for diagnostics, therapeutic monitoring, and transfusion safety. By ensuring accuracy and reproducibility, the Erythrocyte Marker Antibody bridges discovery research with clinical care.

Conclusion

Erythrocytes sustain life through oxygen delivery, and understanding their biology is central to hematology and medicine. The Erythrocyte Marker Antibody equips researchers and clinicians with a dependable reagent for detecting erythrocyte-specific proteins, while Erythrocyte Marker Antibodies more broadly support diagnostics, transfusion medicine, and translational research. By connecting molecular biology with clinical application, these antibodies remain indispensable for advancing science and improving patient outcomes.